导管内乳头状黏液性肿瘤患者伴或不伴胰腺切除术后监测:同时性胰腺导管腺癌发生率
结论认为IPMN患者需长期(≥5年)监测,尤其初始手术时已切除同时性PDAC者继发PDAC风险很高。
要点
- IPMN患者无论是否切除,均需长期(≥5年)监测以警惕同时性PDAC。
- 因同时性PDAC行胰腺切除的IPMN患者,继发PDAC风险显著增高。
- IPMN切除与未切除组的同时性PDAC累积发生率无显著差异。
核心结论
- IPMN患者需长期监测,因存在发生同时性PDAC的潜在风险。
- 初始手术时已切除同时性PDAC的患者继发PDAC风险很高。
研究设计与样本
- 采用Kaplan-Meier法分析同时性PDAC的发生率和时间。
主要发现
- 中位监测40个月(范围6-262个月)期间,PDAC切除组5例、IPMN切除组6例、未切除组8例发生同时性PDAC。
- PDAC切除组继发PDAC的5年累积发生率为17%,10年为56%,显著高于其他两组(P < .01)。
- IPMN切除组与未切除组的同时性PDAC累积发生率无显著差异(5年:5.0% vs 2.2%;10年:5.0% vs 8.7%;P = .87)。
临床怎么用
- 对IPMN患者应进行长期(≥5年)监测,以及时发现同时性PDAC。
- 对初始手术时已切除同时性PDAC的IPMN患者,应加强监测力度。
局限性
- 本研究为回顾性研究,可能存在选择偏倚和信息偏倚。
- 样本量有限,尤其PDAC切除组仅22例。
- 中位监测时间40个月,部分患者随访时间可能不足以评估长期风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The presence of an intraductal papillary mucinous neoplasm is important in the detection of concomitant pancreatic ductal adenocarcinoma. The aim of this study was to elucidate the incidence and timing of development of concomitant pancreatic ductal adenocarcinoma in patients with and without pancreatectomy for intraductal papillary mucinous neoplasm. METHODS: We reviewed retrospectively the surveillance data for 22 patients who underwent pancreatectomy for pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasm (pancreatic ductal adenocarcinoma-resection group), 180 who underwent pancreatectomy for intraductal papillary mucinous neoplasm (intraductal papillary mucinous neoplasm-resection group), and 263 whose intraductal papillary mucinous neoplasms were left untreated (nonresection group). The incidence and timing of the development of a concomitant pancreatic ductal adenocarcinoma during the surveillance of patients with and without partial pancreatectomy for intraductal papillary mucinous neoplasm were investigated using the Kaplan-Meier method. RESULTS: During a median surveillance period of 40 months (range 6-262 months), 5 patients in the pancreatic ductal adenocarcinoma-resection group, 6 in the intraductal papillary mucinous neoplasm-resection group, and 8 in the nonresection group developed concomitant pancreatic ductal adenocarcinoma. The estimated 5-year (17%) and 10-year (56%) cumulative incidences of secondary pancreatic ductal adenocarcinoma in the pancreatic ductal adenocarcinoma-resection group were significantly greater than those in the other two groups (P < .01). Conversely, the difference in the estimated cumulative incidence of concomitant pancreatic ductal adenocarcinoma between the intraductal papillary mucinous neoplasm-resection and nonresection groups was not significant (5-year, 5.0% vs 2.2%; 10-year, 5.0% vs 8.7%; P = .87). CONCLUSION: Long-term (≥5-year) surveillance in patients with intraductal papillary mucinous neoplasm is necessary and important because of the potential for development of concomitant pancreatic ductal adenocarcinoma. Those with a history of resection of concomitant pancreatic ductal adenocarcinoma at the time of the initial operation are at quite high risk for the development of secondary pancreatic ductal adenocarcinoma.
引用
- Date K, Ohtsuka T, Nakamura S, et al. Surveillance of patients with intraductal papillary mucinous neoplasm with and without pancreatectomy with special reference to the incidence of concomitant pancreatic ductal adenocarcinoma. Surgery. 2017. PMID: 29221879. doi:10.1016/j.surg.2017.09.040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。